Compass Pathways

FDA Holds Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace

The FDA held a public hearing on psychedelic drug therapies as part of an administration push to accelerate development for mental illnesses. Priority vouchers were issued to three companies, sparking